A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers

Stephen YoungbergCelerion, Lincoln, NE, USA;

Erin BrandtCelerion, Lincoln, NE, USA;

Avantika BarveNovartis Institutes for BioMedical Research, East Hanover, NJ, USA;

Surendra MachineniNovartis Healthcare Private Limited, Hyderabad, India;

Christopher T. JonesNovartis Institutes for BioMedical Research, Emeryville, CA, USA;

Kristina DabovicNovartis Institutes for BioMedical Research, East Hanover, NJ, USA;

Catherine L. JonesNovartis Institutes for BioMedical Research, Emeryville, CA, USA;

Richard A. ColvinNovartis Institutes for BioMedical Research, Cambridge, MA, USACorrespondence[email protected]

Your download is now in progress and you may close this window